MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026-Archive
Description
This activity provides on-demand archived lectures from the MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 series. The MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026 sessions are designed to increase knowledge among clinicians in an interprofessional setting about controlled substance risk assessment and current evidence-based care models for chronic pain and accessing pain care across underserved populations. We hope to close professional practice gaps utilizing interdisciplinary collaboration, education and training, community engagement, policy and advocacy, and research and innovation.
Course Directors:
Ronald Kulich PhD & Thomas Cheng, MD, PhD & Roxanne Bavarian. DMD, DMSc & Michael E. Schatman, PhD & Matthew G. Fortino, PsyD & Elizabeth Hatfield, DDS & David Alexander Keith, DMD, BDS & Christopher Robinson, MD, PhD
Coordinator:
Ascher Kulich
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at mgbcpd@mgb.org.
You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.
Target audience
This activity is intended for Physicians, dentists, psychologists, nurses, students, residents, fellows with specialties of Oral surgery, Orofacial Pain, Pain Medicine and Sleep Medicine.
Learning objectives
Upon completion of this activity, participants will be able to:
- Identify patients with substance use disorders based on current data on overdose. Participants will be able to state at least two ways the clinician can curb the over-prescription of opioids for pain.
- Use the Prescription Drug Monitoring Program (PDMP) and identify other available screeners for substance misuse.
- List at least one strategy involved and/or resource available to help manage patients with substance misuse, with particular reference to underserved practice groups.
- Recognize three components of interprofessional care that predict improved patient outcomes.
- Summarize one way learning from or with an interprofessional team benefits the patient when treating substance use disorders.
Additional information
Mass General Brigham

Faculty credentials
Course Directors
Ronald Kulich PhD
Thomas Cheng, MD, PhD
Roxanne Bavarian. DMD, DMSc
Michael E. Schatman, PhD
Matthew G. Fortino, PsyD
Elizabeth Hatfield, DDS
David Alexander Keith, DMD, BDS
Christopher Robinson, MD, PhD
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. All reviewers have no relevant relationships with ineligible companies.
The following planners have reported no relevant financial relationship with an ineligible company:
Roxanne Bavarian. DMD, DMSc
Gary Brenner, MD, PhD
Jennifer Cheng, CNP
Thomas Cheng, MD, PhD
Kathryn Dolan, RDH
Matthew G. Fortino, PsyD
Elizabeth Hatfield, DDS
Mohammed A. Issa, MD
David Alexander Keith, DMD, BDS
Anna Kim, RN
Ronald Kulich PhD
Robert Nersasian , DMD
Christopher Robinson, MD, PhD
Michael E. Schatman, PhD
Michael A. Scialabba, DDS
Christine Sieberg, PhD
Donna Sultan, MBA
Yuanming Xu, DDS, MMSc
Yi Zhang, MD, PhD
The following planners have reported a relevant financial relationship with an ineligible company:
Robert Jason Yong, MD, MBA
Consultant: Medtronic, Boston Scientific, Nevro, Biotronik, Abbot
Carol Warfield, MD
Consultant: Abbvie, Johnson & Johnson (ended)
Accreditation
ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dentist
Mass General Brigham is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Mass General Brigham designates this activity for 1 continuing education credit.
Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Psychology
1 Continuing Education (CE) credit are awarded
*Some sessions in this activity are designed to meet the criteria for risk management study in Massachusetts.
Program
| Date of Live Session | Subject | Speaker |
|---|---|---|
|
September 17, 2025 |
MGH/Harvard Interdisciplinary Pain and Headache Rounds 2025-2026: Introductory Keynote Presentation: Discovery, First Demonstration and Dissemination of Ether at MGH, 1846 |
Leonard Kaban, DMD, MD, FACS |
| September 24, 2025 |
The Future of Pain Medicine and Pain Care in the United States: Where We Are, Where We Need to Go |
Antje M. Barreveld, MD |
| October 1, 2025 |
Health, Equity, and Pain Care |
Jaleesa Jackson, MD |
| October 8, 2025 |
Neurosurgical Considerations for the Treatment of Trigeminal Neuralgia |
Chetan Bettegowda, MD, PhD |
| October 15, 2025 |
19th Century Women Physicians Treating Pain: Bias, Bigotry, and the Men Who Supported Their Training |
Ronald Kulich, PhD |
| October 22, 2025 |
Substance Use Disorder Assessment and Care for Medically Underserved Populations (MUPS) |
Matthew Fortino, PsyD |
| October 29, 2025 |
Orofacial Pain and Sleep Comorbidity Interplay |
Gilles Lavigne, DMD, MSc, PhD, FRCD |
| November 5, 2025 |
The Eternal Debate About the Utility of Spine Injections |
Jane Ballantyne, MD, FRCA |
| November 12, 2025 |
New Headache Treatments: Evidence, Affordability, and Accountability |
Elizabeth Loder, MD, MPH |
| November 19, 2025 |
HC-sparing Effects of Cannabis Constituents: Potential to Reduce Harms and Improve Outcomes |
Ziva D. Cooper, PhD |
| December 3, 2025 |
Sleep Disorders and Pain |
Patrick Finan, PhD |
| December 10, 2025 |
Surgical Management of Trigeminal Neuralgia |
Jeffrey Schweitzer, MD, PhD |
| December 17, 2025 |
Junk Science, Evidence, and the Management of Pain |
Jonathan Jarry, MSc |
| January 7, 2026 |
Electromyography in the Content of Pain Assessment |
Reza Seyedsadjadi, MD |
| January 14, 2026 |
Pain in Head and Neck Cancer |
Khawaja Shehryar Nasir, BDS |
| January 21, 2026 |
Update on Current Evidence of Cannabis Use for Pain |
Paul Christo MD, MBA |
| January 28, 2026 |
The Role of Adaptive Sports in Chronic Pain |
Jennifer Packard, OTRL/L |
| February 4, 2026 |
Elderly and Pain Medicine |
Christine Ritchie, MD, PhD |
| February 11, 2026 |
Current Status of Pain Medicine and the Construct of Spectrum Disorders |
Daniel Clauw, MD |
| February 18, 2026 |
The ‘4 Ps’ of Pain Medicine: Patients, Providers, Payers, and Profits |
Michael Schatman, PhD |
| February 25, 2026 |
Post-traumatic Trigeminal Neuropathy |
Tara Renton BDS, MDSc, PhD |
| March 4, 2026 |
Relevance Based Prediction (RBP) for Spinal Cord Stimulation Outcomes |
Mark Kritzman |
| March 11, 2026 |
Pharmacotherapies for Migraine: Bench to Bedside |
Messoud Ashina, MD, PhD, DMS |
| March 18, 2026 |
Diagnosis of Overlapping Orofacial Pain Diseases and Disorder |
Donald Nixdorf, DDS, MS |
| March 25, 2026 |
Basic Mechanisms in Migraines |
Sait Ashina, MD |
| April 1, 2026 |
April Fools’: Regenerative Medicine: A Prank or Reality |
Christopher Robinson, MD, PhD |
| April 8, 2026 |
Evidenced-Based PT Approaches to Pain |
Moreza Bahar, BPT, DPT, MSc |
| April 15, 2026 |
Immune Modulation for Neuropathic Pain: Translational Insights from Spinal Cord and Peripheral Nerve Stimulation |
Eellan Sivanesan, MD, FASA |
| April 22, 2026 |
Pharmacogenetics of Orofacial Pain |
Amy Pasternak, DMD |
| April 29, 2026 |
Retracted Publications in Pain Medicine |
Michael Ferraro, BSc (Hons), BHSc and Neil O’Connell, PhD, MSc, BSc (Hons), PGCert |
| May 6, 2026 |
Sickle Cell and Pain |
Robert Jason Yong, MD, MBA |
| May 13, 2026 |
Pediatric Obstructive Sleep Apnea (OSA) |
Mitchell Levine, DMD, CAGS, MS |
| May 20, 2026 |
Spine and Musculoskeletal Pain Conditions |
Zachary McCormick, MD |
| May 27, 2026 |
Management of Opioid Use Disorder (OUD) and Pain |
Samata Sharma, MD |
-
Price
$500.00 - Register for this course